Bringing the fundamentals into focus…
Back to Harmony Biosciences Holdings, Inc.
How Harmony Biosciences Holdings, Inc. stacks up
HRMY · against 388 other Healthcare companies of similar size
Profitability
95/ 100
Near the top of its peers.
Ranked #21 of 389 · scores higher than 94% of peers
Bars: peers in each 10-point band of the profitability score45 peers with a profitability score of 90–100, including HRMY · Click a bar to see the companies
Why profitability scores 95?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its return on assets, return on invested capital and operating margin, which are stronger than most Healthcare peers.
- a wider operating margin: stronger than 87% of peers. Operating margin: 24.0% vs peer median 7.1%
- a higher return on invested capital: stronger than 93% of peers. Return on invested capital: 30.2% vs peer median 4.7%
- a higher return on assets: stronger than 94% of peers. Return on assets: 13.2% vs peer median 1.7%
Metric by metric
Position: dot = HRMY, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | HRMY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 366 reported | 30.2% | 6.1% | 92% | 33% | |
| Operating marginHigher is better · 359 reported | 24.0% | 8.4% | 84% | 33% | |
| Return on assetsHigher is better · 372 reported | 13.2% | 2.1% | 94% | 33% | |
| Return on equityHigher is better · 357 reported | 20.5% | 5.2% | 91% | Context only | |
| Gross marginHigher is better · 403 reported | 75.4% | 48.7% | 83% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around HRMYScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score